Related Experiment Videos
[Clinical staging of prostate cancer]
K Okada1, Y Yamanaka, T Hachiya
1Department of Urology, Nihon University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 29, 1998
Summary
The 1997 TNM classification for prostate cancer staging was revised, introducing new categories for T1c, T2 (T2a, T2b), and T3 (T3a, T3b) tumors. These updates aim to improve the detection of tumor burden in cancer patients.
Area of Science:
- Urology
- Oncology
- Cancer Staging
Context:
- Review of the Union Internationale Contre le Cancer (UICC) TNM classification for prostate cancer staging.
- Focus on the 1997 revision and its implications for clinical practice.
Purpose:
- To detail the specific revisions made to the TNM classification for prostate cancer in 1997.
- To highlight the new subcategories introduced for T1, T2, and T3 tumor stages.
Summary:
- Introduction of T1c for high PSA levels without abnormal digital rectal exam (DRE) findings.
- Subdivision of T2 into T2a (unilateral) and T2b (bilateral) nodules.
- Subdivision of T3 into T3a (capsular invasion) and T3b (seminal vesicle invasion).
Impact:
- Aims to provide more precise tools for assessing prostate cancer tumor burden.
- Facilitates more accurate staging and potentially treatment planning.
- Enhances the understanding of localized and locally advanced prostate cancer characteristics.